Scotland’s vaccination drive appears to be markedly reducing the risk of hospitalisation for COVID-19, suggesting that both the Pfizer-BioNTech and Oxford-AstraZeneca shots are highly effective in preventing severe infections, preliminary study findings showed on Monday.
Results of the study covering the entire Scottish population of 5.4 million showed that by the fourth week after the initial dose, the Pfizer and AstraZeneca vaccines cut the risk of hospitalisation by up to 85 per cent and 94 per cent respectively.
“These results are very encouraging and have given us great reasons to be optimistic for the future,” said Aziz Sheikh, a professor at the University of Edinburgh who co-led the study.
Read more: Canada to receive over 640,000 vaccine doses from Pfizer, Moderna this week
Sheikh cautioned that the results are preliminary and have yet to be peer-reviewed by independent scientists, but told a media briefing: “I am very encouraged. We now have national evidence … that vaccination provides protection against COVID-19 hospitalisations.”
He expected other countries using the same vaccines and similar roll-out strategies – such as England and Wales – would see a similar positive impact in reducing numbers being hospitalised.
Flying back to Canada? Here’s what you can expect at the new COVID-19 quarantine hotels
No sympathy for snowbirds: Most Canadians support travel restrictions, Ipsos poll finds
Read more: Coronavirus: Hajdu says Canada in talks with Pfizer over update to freezer requirements